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ABSTRACT 
 
Genomic Analyses of Induced Hypercholesterolemia and Atherosclerosis in a Mixed 
Breed Colony of Dogs and Developmental Abnormalities in the Havanese.      
(December 2007) 
Alison Nicole Starr, B.S. Clemson University 
Chair of Advisory Committee: Dr. Keith E. Murphy 
 
 The domestic dog, Canis lupus familiaris, is a unique model system for the 
dissection of hereditary diseases. Selective breeding practices have created more than 
300 distinct breeds of dogs, born from a desire to create specific physical and behavioral 
characteristics. Breeds represent closed breeding populations and the extensive records 
maintained for members of each breed (e.g., multi-generational pedigrees, veterinary 
medical records) present an incredible tool for genetic research. Two closed populations 
were used in the work presented here: a colony of mixed-breed dogs segregating 
resistance and sensitivity to cholesterol feeding, and a purebred pet population of 
Havanese experiencing a high frequency of developmental abnormalities. 
 Estimates of heritability were calculated for each disease to evaluate the degree 
of phenotypic variation attributable to genetics among dogs in the populations used. A 
heritability of 0.55 (± 0.16) was identified for cholesterol resistance and sensitivity in the 
mixed-breed colony. The small sample size prevented the use of complex segregation 
analyses to examine mode of transmission.  A heritability of 0.36 (± 0.26) was calculated 
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for the composite phenotype in the Havanese, encompassing the spectrum of 
abnormalities in the breed. Polygenic inheritance was identified for the composite 
phenotype, but the action of a major gene was identified by complex segregation 
analyses in the Havanese.  
Complex diseases preclude the use of a candidate gene approach, owing to the 
multitude of genes involved in the disease process. Whole genome screens provide a 
practical approach to the identification of chromosomal region(s) associated with a 
disease phenotype by narrowing the search for candidate gene(s).  The Minimal 
Screening Set – 2 (MSS-2) was used in the present studies to evaluate the segregation of 
microsatellite markers in pedigrees for both the mixed-breed colony and the Havanese. 
No significant LOD scores were identified, though suggestive LOD scores were 
obtained in both analyses.  
A canine-specific oligonucleotide microarray was used to create gene expression 
profiles for developmental abnormalities in the Havanese and for cholesterol sensitivity 
in the mixed-breed colony dogs. Distinct expression profiles were generated for each 
group, and several genes of interest were identified as being both differentially expressed 
(>±2-fold change) and statistically significant (p-value<0.05).  
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CHAPTER I 
 
INTRODUCTION: THE DOG AS A MODEL 
 
 
All knowledge, the totality of all questions and all answers, is contained in 
the dog.  ~Franz Kafka 
 
 
Canine genetics 
Among mammals, the domestic dog (Canis lupis familiaris) is the most diverse 
species, unequaled with respect to its varying morphology, coat color and behavior. 
Fossil records indicate the wolf was domesticated approximately 15,000 years ago 
(Savolainen et al. 2002), and the present-day dog population diverged exclusively from 
these early domesticated wolves (Vilà et al. 1997). Selective breeding practices have 
produced more than 300 breeds of dog (FCI 2007). These breeds were borne from a 
desire to create companion animals with specific behavioral and physical characteristics. 
Each breed is a closed population, and as such, has limited genotypic and phenotypic 
heterogeneity caused by founder events, population bottlenecks, and the use of popular 
sires. This unique population structure, along with detailed pedigrees, short gestation 
time, large litter size, and superior medical surveillance, makes the dog a valuable tool 
for the dissection of genetic traits. 
Over 480 hereditary diseases have been described in the dog and more than 200 
of these have decidedly similar clinical presentations to corresponding diseases of the 
human (OMIA 2007). The aforementioned breeding practice designed to produce dogs  
____________ 
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with specific traits has had an undesired consequence: the propagation of autosomal 
recessive diseases. The presence of deleterious alleles, when combined with the common 
practice of inbreeding, results in the mating of asymptomatic carriers. This obviously 
increases the number of autosomal recessive diseases (Ostrander et al. 2000) Almost half 
(46%) of the hereditary diseases in the dog occur largely in one or a few breeds 
(Patterson 2000, Sargan 2004). The natural occurrence of these conditions makes the 
dog a more valuable model than the mouse, whose widely studied disease models are 
primarily induced. The dog also has a longer life span and a more comparative 
body/tissue size with the human than does the mouse.   
Canine genomics 
Many recent advances in canine genomics have accelerated research of canine 
hereditary diseases. Most notably, the completed 7.6X sequence of the canine genome 
(Lindblad-Toh at al. 2005) has provided the ultimate tool for genetic research and has 
aided the development of canine-specific oligonucleotide arrays and single nucleotide 
polymorphism (SNP) arrays for large-scale genomic studies. These new technologies 
can be used to create disease profiles and identify candidate genes or pathways 
responsible for the disease, or for disease progression.  
 The canine genome is comprised of 38 pairs of autosomes, plus the X and Y sex 
chromosomes. From sequence analysis, the genome has been determined to be 2.4 
gigabases (109 bases) in size (Lindblad-Toh et al. 2005). The most recent estimate of the 
number of canine genes is 19,000; approximately 75% of these are orthologous among 
dog, mouse, and human (Parker and Ostrander 2005). 
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Cytogenetic studies, including a standardized karyotype (Breen et al. 1999) and 
radiation hybrid (RH) maps (Priat et al 1998, Vignaux et al 1999, Breen et al 2001), have 
facilitated the development of maps of the dog that cane be compared to various species 
(Sargan et al. 2000). The identification and localization of both markers (i.e., 
microsatellites, SNPs) and specific genes has yielded insight into genome conservation 
and rearrangement. From these studies, it is clear that the canine genome is remarkably 
similar to the human genome; e.g., from a comparative standpoint there are low levels of 
chromosomal rearrangements in the two genomes. The numbering of canine 
chromosomes, mapping of markers and genes, has been indispensable to chromosome-
specific approaches to genome screens. 
Linkage analyses 
Linkage maps (Mellersh et al. 1997, Breen et al 2001) and multiplexed 
microsatellite screening sets (Cargill et al. 2002, Clark et al. 2004) have streamlined 
studies designed to identify regions of the genome that harbor causative genes or 
quantitative trait loci (QTLs). The complexity of many diseases - with many genes and 
pathways known to play a role in disease initiation and progression - prohibits the use of 
a candidate gene approach, thus necessitating the use of linkage analyses, either classical 
linkage or linkage disequilibrium (LD). Classical linkage analyses trace allele identity-
by-descent using multi-generational pedigrees (minimum of three generations). This 
approach is based on the number of alleles shared among family members at specific 
chromosomal loci, and the associated phenotypic similarity between these members.  
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Classical linkage is informative for well-described families in which the 
segregation of disease over several generations can be observed, and every family 
member can be accounted for. The limitations of classical linkage are that it requires 
detailed, informative pedigrees and samples from all members of the family. These 
constraints make the LD approach to association studies more attractive. LD uses 
unrelated affected and unaffected dogs in screens of the genome for alleles that are 
conserved among members of the groups. Recent advances in association studies (Sutter 
et al. 2004, Parker et al. 2004) highlight the use of LD for mapping disease traits of the 
dog. Linkage analyses, classical or LD, do not detect specific gene(s). Rather, regions of 
the genome within which candidate genes reside are identified by linkage analysis.  
Population structures for research 
Atherosclerosis and physiologic development are two examples of conditions 
under complex genetic control. Many pathways and genes are known to contribute to the 
development of both atherosclerosis and embryonic patterning, complicating the study of 
these conditions. Two distinct population structures were used to investigate these 
complex traits: a cross-bred, Labrador-hound (Lab-mix) population segregating extreme 
phenotypes, and a purebred population with a variable, syndrome-like phenotype.  
The Lab-mix population demonstrates a cross-bred pedigree segregating extreme 
phenotypes in response to cholesterol feeding: cholesterol sensitivity leading to the 
formation of atherosclerotic lesions, and cholesterol resistance with no associated 
lesions. The dogs were initially bred for use as surgical models for human angioplasty, 
but when the breeding colony began segregating different phenotypic responses to 
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cholesterol feeding, the investigators became interested in the genetics underlying the 
phenotypic differences, and whether the process of atherosclerosis in the dog would 
mimic human atherosclerosis. Atherosclerosis is known to be a complex disease with 
multiple environmental and genetic factors contributing to the disease presentation. It 
has been suggested that for the study of complex diseases, a restricted population of only 
those family members segregating the most extreme phenotypes should be used to 
increase the power of linkage studies (Risch and Zhang 1995). In doing so, the amount 
of genetic variation among family members sharing the same phenotype is decreased, 
and between the extremes, is maximized. In short, the high degree of inbreeding in 
closed populations facilitates the search for disease-causing genes by decreasing the 
polymorphisms that exist in open populations.  
The purebred domestic dog provides researchers with perfect tool for the study of 
hereditary diseases. That is, the closed breeding populations of purebred dogs contain 
individuals who are largely homogeneous at the phenotypic and genotypic levels. The 
Havanese breed originated in Cuba, with descriptions dating back to the 1700’s. In the 
1970’s, Havanese were introduced in the United States (US) by eight founding dogs. 
Havanese kindred from Hungary, Costa Rica, and Cuba have been added in the last 
twenty years to the US Havanese population (D. Klumb, personal communication).  
Atherosclerosis 
Hypercholesterolemia is directly associated with the development of 
atherosclerosis, coronary heart disease (CHD), and stroke. Prolonged 
hypercholesterolemia often leads to the development of atherosclerosis. The clinical 
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complications of atherosclerosis include myocardial infarction (MI), CHD, and stroke. 
Over 35 million Americans have cholesterol levels in the range that places them at risk 
(greater than 240 mg/dL) for developing CHD or stroke (American Heart Association 
(AHA) 2007). CHD is the leading cause of death in the United States, and stroke is the 
third leading cause of death (AHA 2007). For these reasons, research into risk factors, 
disease progression, and treatment protocols for atherosclerosis is important.  
In humans, an excess of low-density lipoprotein (LDL) circulating in the plasma 
causes macrophages to express scavenger receptors that bind the free LDL. 
Macrophages lack a feedback mechanism to regulate intracellular cholesterol levels, 
resulting in an accumulation of cholesterol in the cytoplasm. The accumulation of 
cholesterol-filled macrophages (foam cells) in the subendothelium leads to the 
development of fatty streak lesions – the first visible abnormality of the vascular wall. 
An inflammatory reaction is induced by the disruption of the vascular wall integrity. 
Smooth muscle cells (SMCs) immigrate to the fatty streak from the medial layer, 
producing an early atheroma with a fibrous cap. In advanced lesions, calcification, 
ulceration, and hemorrhage of small vessels can disrupt the lesion stability. The most 
serious health threat in atherosclerosis is that of arterial occlusion, either resulting from a 
chronic or acute condition. Chronic conditions are caused by large, advanced lesions that 
block the blood flow in a vessel. Acute occlusion results from the rupture of a plaque, 
releasing necrotic material from the center of the plaque. When this material reacts with 
the blood components, a thrombus forms, and it may become lodged in small arteries 
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thereby causing myocardial infarction or stroke, depending in which tissue the occlusive 
thrombus occurs.  
Because atherosclerosis is known to involve both genetic and environmental 
factors, having a controlled, uniform environment for all study participants minimizes 
external factors which may complicate human studies of atherosclerosis. For this reason, 
the colony of Lab-mix dogs is a particularly powerful tool as a large animal model of 
atherosclerosis.  
Developmental abnormalities 
 A multitude of abnormalities arising from aberrant embryonic development have 
been described in virtually every species. Embryonic development is a highly regulated 
process requiring the precisely coordinated actions of many genes, and the disruption of 
these genes and tightly-controlled pathways are responsible for many birth defects. One 
such pathway is that of cholesterol biosynthesis. The disruption of any gene involved in 
cholesterol biosynthesis results in a syndrome of developmental abnormalities; including 
cleft palate, open fontanel, facial dysmorphes, toe syndactyly, and chondrodysplasia 
(Nwokoro et al 2001). Cholesterol is an essential component of development and it acts 
as the covalent adduct for the hedgehog proteins (Porter et al 1996).  
The hedgehog (Hh) proteins are a family of signaling molecules involved in 
embryonic patterning (Porter et al 1996). Disruption of the cholesterol biosynthesis 
pathway prevents endogenous production of cholesterol, directly affecting the ability of 
Hh proteins to function in enbryogenesis (Cooper et al 2003). Members of the Hh family 
 
 8
include sonic hedgehog (Shh), desert hedgehog (Dhh), and Indian hedgehog (Ihh). Shh 
dysfunction results in abnormal development of the brain, skeleton, and gonads.  
The Havanese breed has presented with open fontanels, cleft palates, 
hydrocephalus, cryptorchidism, osteochondrosysplasia, luxating patellas, elbow 
dysplasias, Legg-Calve-Perthes, liver shunts and hepatic microvascular dysplasias, heart 
murmurs, atrial septal defects, cataracts, deafness, and missing incisors. The incidences 
of each of these conditions within the breed are unknown, but a number of the 
abnormalities are strikingly similar to abnormalities produced in cholesterol biosynthesis 
disorders.   
Heritability and CSA 
Heritability is a measure used to estimate the proportion of phenotypic variation 
which can be attributed to genetic variance in a sample population. This estimate is 
calculated for non-Mendelian traits to predict the response to selective breeding. 
Heritability is measured from a scale of 0 to 1, such that a score of 0 indicates no genetic 
contribution, and a score of 1 indicates total genetic control. Various studies of 
atherosclerosis in the human have estimated heritabilities between 0.21 and 0.92, 
depending on the method of measurement of atherosclerosis. The heritability of 
atherosclerosis in the dog has not previously been reported. The abnormalities in the 
Havanese have not been investigated prior to the present study, therefore no heritability 
estimates exist.  
Complex segregation analyses (CSA) are used to evaluate various modes of 
disease transmission in a defined pedigree to identify the pattern of inheritance which 
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has the best statistical fit. This is accomplished through use of computer modeling 
programs, CSA characterizes a trait as exhibiting either Mendelian inheritance (i.e., 
autosomal recessive, autosomal dominant, X-linked) or a non-Mendelian inheritance 
(i.e., polygenic, multifactoral). 
Complex diseases result from interplay of genetic and environmental factors. 
One consequence of such interactions of multiple genes is that there may be one which 
exerts a greater influence in phenotypic expression; this is designated a major gene. 
Complex diseases are precluded from having a simple inheritance pattern; however, the 
action of a major locus can be detected using CSA.  
Rasch models 
Rasch modeling is a frequently employed approach in psychology, sociology and 
education to measure such traits as abilities and attitude. This approach is particularly 
used in psychometrics, or those fields concerned with the psychological or educational 
measurement. In such fields, behaviors and abilities are analyzed. These traits, in 
essence, are complex traits. Both environment and genetics play a role in the 
development of specific behavior or ability. Thus, this approach in education and 
psychology may very well be directly applicable to the study of complex disease in the 
biomedical research and may provide powerful insight into the phenotype of interest by 
measuring many traits for simultaneous analysis. Rasch models have not previously been 
used in canine genetics, and the inclusion herein provides the first evidence of how 
conventional statistical approaches (e.g., heritability, CSA) can be integrated with novel 
approaches to measurement of traits.  
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Objectives 
The specific objective of this work was to study the genetics of two different 
population structures of dogs segregating complex diseases.  To accomplish this 
objective, it was necessary to (1) assemble multigenerational pedigrees for both the Lab-
mix and Havanese samples, (2) complete estimates of heritability and complex 
segregation analyses for Lab-mix and Havanese pedigrees, (3) perform linkage analysis 
on Lab-mix and Havanese kindred for atherosclerosis susceptibility loci and loci 
contributing to developmental abnormalities, respectively, and (4) develop gene 
expression profiles for cholesterol-resistant and sensitive dogs, as well as affected 
Havanese, using an oligonucleotide array. 
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CHAPTER II 
HERITABILITY AND GENETIC EVALUATION OF INDUCED 
HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS IN THE DOMESTIC 
DOG 
 
Overview 
Hypercholesterolemia and atherosclerosis are major health concerns and, to date, 
research has been focused on genetic and environmental contributing factors that 
contribute to these diseases as well as on treatment. Familial associations exist in 
humans, and studies have confirmed a polygenic mode of transmission. Several models 
of hypercholesterolemia and arteriosclerosis exist. For example, an induced model of 
atherosclerosis has been developed in a colony of mixed breed dogs. Described herein 
are the heritability studies, linkage analyses, and global gene expression data generated 
as part of the investigation of induced hypercholesterolemia and atherosclerosis in the 
domestic dog.  
Introduction 
Hypercholesterolemia is directly associated with the development of 
atherosclerosis, coronary heart disease (CHD), and stroke. Over 35 million Americans 
have cholesterol levels in the range that places them at risk (greater than 240 mg/dL) for 
developing CHD or stroke (American heart assoc 2007). CHD is the leading cause of 
death in the United States, and stroke is the third leading cause of death (AHA 2007). 
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For these reasons, research into risk factors, disease progression, and treatment protocols 
for hypercholesterolemia and atherosclerosis is critical.  
Both large and small animal models of atherosclerosis exist for the study of 
disease susceptibility, initiation, progression, and treatment. Animal models of 
atherosclerosis include primates, the pig, dog, rat, mouse, and rabbit. A brief summary of 
these models of atherosclerosis compared to human atherosclerosis is outlined in Table 1 
(Russell and Proctor 2006, Blanton and Peeters 1976, Yanni 2004). No single model of 
atherosclerosis is without shortcomings, and the data produced from studies of model 
animals are not easily extrapolated to the human. 
 
Table 1: Comparison of the animal models of atherosclerosis to the natural 
atherosclerosis in humans.  
 
Model Phylogenetically close to human Metabolism Diet 
Atherosclerosis 
development 
Primate +++ Similar Omnivore Natural and Induced 
Pig ++ Similar Omnivore Induced 
Dog ++ Dissimilar Carnivore Induced 
Rabbit + Dissimilar Herbivore Induced 
Rat + Similar Omnivore Induced 
Mouse + Similar Herbivore Induced 
 
 
 
The dog has been used as a model for many human hereditary diseases, both with 
single gene and complex inheritance patterns (for reviews see: Ostrander et al. 2000, 
Sutter and Ostrander 2004, Switonski et al. 2004, Tsai et al. 2007). Spontaneous cases of 
atherosclerosis in the pet population are predominantly secondary to another disturbance, 
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e.g., hypothyroidisim, diabetes mellitus, or microorganism infection (Sottiaux 1999, 
Sako et al. 2002, Hess et al. 2003). Accordingly, canine atherosclerosis in the research 
setting results from manipulation of thyroid function (Rawitscher et al. 1973, Sabiston et 
al. 1961, Steiner et al. 1949) or surgical intervention (Pertsemlidis et al. 1973, Rapold et 
al. 1992, Deng et al. 1994). Experimental models of atherosclerosis in the dog, when 
compared to other models of atherosclerosis, show a similar distribution of lesions as 
related to age to the human (Weinberg 2004).  
 A colony of Lab-mix dogs which segregates cholesterol-sensitive and 
cholesterol–resistant phenotypes has been developed. These dogs are suitable for long-
term studies of cholesterol-supplemented diets, in contrast to the rabbit, in which 
hepatotoxicity develops from long term cholesterol-feeding (Yanni 2004). Dogs have 
been successfully maintained on the high-cholesterol diet for up to one year. The dogs, 
when intermittently challenged with cholesterol, have a lifespan of 9 - 12 years, 
comparable to a Labrador-mix breed pet lifespan of 10 and 14 years.  
Many dogs challenged with the cholesterol diet exhibit dermatologic 
abnormalities (dry, flaky skin) and otitis externa. These abnormalities occur 
predominantly in the sensitive dogs and are attributed to impaired circulation. A diet 
change to regular dog chow resolves these abnormalities.  
The Lab-mix model of atherosclerosis was developed by selective breeding for 
sensitive and resistant dogs. The normal cholesterol level in the dog is 116-254 mg/dL. 
Upon the challenge of dietary cholesterol, a continuum of cholesterol levels is observed. 
Dogs are classified as sensitive, resistant, or average based on the response to the dietary 
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challenge. Only the most sensitive (cholesterol >900 mg/dL) and resistant dogs 
(cholesterol <400) were used to propagate the colony. Dogs exhibiting an average 
response (~600-890 mg/dL) to the cholesterol challenge were not included in this study. 
The dog has traditionally been thought of as a naturally cholesterol-resistant 
species (Abell et al. 1956, Pertsemlidis et al. 1973). Dogs are extremely efficient at 
maintaining cholesterol homeostasis with their ability to increase or decrease cholesterol 
excretion and/or cholesterol biosynthesis in response to dietary cholesterol intake 
(Pertsemlidis et al 1973). Dogs also have a protective mechanism against myocardial 
infarction because of the development of collateral myocardial arteries (Helisch and 
Schaper 2003). The main transporter of cholesterol in the dog is HDL. Nearly 87% of 
lipoprotein content in the dog is HDL, with ~11% lipoprotein as LDL, in direct inverse 
to man (~11% and 86%, respectively) (Maldonado et al. 2001). While this inverse 
correlation between dogs and the human with respect to lipid metabolism may appear to 
pose a limitation of the canine model, it should be noted that lipid metabolism in the 
mouse and rat are also based on HDL (Russell and Proctor 2006).  
Presented here are the genetic analyses of induced hypercholesterolemia and 
atherosclerosis in a colony of mixed-breed dogs.  
Materials and methods 
Dogs 
The Lab-mix dogs in this study were fed an atherogenic test diet (Harlan Teklad 
Laboratory Diets, Madison, WI) comprised of 5% cholesterol by weight. The dogs used 
in this study weigh between 30 and 40 kgs. Twenty-seven dogs were given 2.8 kg of diet 
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per day ad libitum. The dogs were maintained on the diet for 12 months. Each dog had 
venous blood drawn monthly to monitor cholesterol (Cholestech LDX, Cholestech 
Corp., Hayward, CA), serum chemistries (VetTest, IDEXX, Westbrook, ME) and 
complete blood counts (CBC) (Forcyte, Oxford Science, Oxford, CT). Tissues were 
collected from dogs at the time of necropsy. 
A five-generation pedigree was assembled for the Lab-mix dogs. The pedigree 
contained 84 dogs: 38 females and 46 males. These dogs include the 27 fed the 
cholesterol diet and 56 additional dogs, completing sibling and parent relationships (Fig 
1).   
Linkage 
Twenty-eight dogs were selected for a whole genome screen using the MSS-2, a 
multiplexed, canine-specific collection of microsatellite markers (Clark et al. 2004). 
Whole blood was collected from each dog and DNA was isolated using the Puregene 
DNA Isolation kit (Gentra Systems, Minneapolis, MN).  
Four fluorescent dyes were used to label the forward primers, and the PCR 
protocol described by Clark et al. (2004) was modified for the use of robotics (Bio-Tek 
Precision 2000, Winooski, VT).  Stocks of DNA were maintained at 12.5 ng/µl and 4 µl 
of DNA was added for a total of 50ng of DNA to each reaction. As a result, no ddH2O 
was added to the reaction. PCR products were resolved on an ABI 3730 sequencer 
(Applied Biosystems, Foster City, CA) with an internal size standard (Gene Scan 500 
LIZ, Applied Biosystems). Genotypes were assigned using Genemapper® software v3.7 
(Applied Biosystems). 
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Figure 1: Lab-mix kindred for the sensitive (grey) and resistant (white) dogs. Sensitive dogs marked with a maroon circle 
experienced a stroke. The five dogs selected for the gene expression studies are indicated with (*). Average cholesterol levels 
(mg/dL) for each dog over the course of the cholesterol challenge are listed below each individual. (†) Dog died suddenly in 
the middle of the study, so this number is the average of months measured.  
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Two-point LOD scores were calculated using the SOLAR software package 
version 2.1.5 (Almasy and Blangero 1998). Each dog was assigned two phenotypes: 
either cholesterol setsitive (1) or cholesterol resistant (0), and a continuous cholesterol 
level for evaluation.  
Global gene expression 
Gene expression in the Lab-mix was assessed using the Affymetrix canine 
genome 2.0 array (Santa Clara, CA). The array contains 42,929 total probe sets (controls 
included). Eighteen thousand transcripts are canine-specific and more than 20,000 
predicted gene sequences are included based on homology with known genes in other 
species.  
Two resistant and three sensitive dogs were selected for the expression study. 
The sensitive and resistant dogs can trace common ancestry through a male and female 
four generations previous.  The two resistant dogs were full-siblings. Two of three 
sensitive dogs were full-siblings; the third was a half-sibling. (Figure 1). All five dogs 
were age-matched.   
 Samples from the heart, liver, and brain were collected from the five dogs at the 
time of euthanasia and necropsy. Tissue was stored in RNAlater® (Ambion, Austin, 
TX). RNA isolated from the tissues was prepared by Viagen Inc. for hybridization to the 
Affymetrix canine 2.0 array using the classic protocol (Chomczynski and Sacchi 1987). 
Ambion’s linear amplification kit, MessageAmpTM aRNA Kit (Ambion Inc.), was used 
for first- and second-strand cDNA, and biotin-labeled cRNA synthesis. Two micrograms 
of total RNA were used to start the single round of amplification. All samples were run 
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in duplicate. Fragmentation of the labeled cRNA was performed by incubating the 
samples at 95˚C for 35 minutes in a solution containing 40mM Tris-acetate (pH 8.1), 
100mM KOAc, and 30mM MgOAc. Forty micrograms of the fragmented, labeled cRNA 
was then hybridized to each of the GeneChip® (Affymetrix) oligonucleotide arrays. 
These arrays were washed, stained, and scanned in accordance with a previously 
published protocol (Ji et al. 2004). 
High-resolution GeneChip images were collected on the GeneChip Scanner 
3000. Affymetrix GeneChip operating software was used to quantify image data and 
calculate gene expression values.  
 GeneSpring software (Silicon Genetics, Redwood City, CA) was used to perform 
gene clustering, Students’ t-test, and Bonferroni multiple testing corrections. Samples 
were grouped separately to identify differentially expressed genes.  
Results 
Dog response to diet 
Sensitive dogs fed an atherogenic diet longer than 3 months had dramatic 
increases in serum cholesterol levels and subsequent development of atherosclerotic 
lesions in small arteries (i.e., femoral arteries, iliac a., coronary a., circle of Willis). 
Resistant dogs fed the high-cholesterol diet responded with small to moderate increases 
in serum cholesterol but developed no lesions, despite the one-year feeding period. The 
average cholesterol level of sensitive dogs was 1237 mg/dL, compared to the average 
424 mg/dL in resistant dogs, when challenged with the atherogenic diet. 
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Estimate of heritability 
Table 2 presents evidence showing that atherosclerosis, as measured by 
cholesterol levels, is an inherited disorder in the Lab-mix. The estimate of heritability of 
0.550 (± 0.16) supports a significant heritable component for this illness. Additionally, a 
binary scoring system of 0 (resistant) and 1 (sensitive) was evaluated for heritability. 
The estimates for this trait were 0.582 (± 0.21).  
 
Table 2: Estimate of heritability in a threshold model for the continuous cholesterol 
levels and the binary score of atherosclerosis.  
 Estimate Standard Error 
Cholesterol level 0.550 0.16 
Binary score 0.582 0.21 
 
 
 
 
Linkage 
 
 Two-hundred and five microsatellite markers were genotyped and analyzed for 
linkage with the cholesterol phenotype. The maximum LOD score attainable from this 
pedigree was determined to be 1.8, based on a perfectly segregating autosomal recessive 
trait. Using the cholesterol trait, four markers had LOD scores which suggested further 
investigation: CPH14 (CFA05) 1.06, REN162C04 (CFA07) 0.96, AHT137 (CFA11) 
0.89 and C11.873 (CFA11) 1.24. The binary trait had only two markers with LOD 
scores > 0.80 and both were located on CFA11: C11.873 (0.85) and FH2004 (0.89). 
 
 
 20
Global gene expression 
The second generation canine Affymetrix oligonucleotide array was used to 
assess gene expression in resistant and sensitive tissues. A disease profile for 
atherosclerosis in the heart, liver, and brain tissues was created. The sensitive and 
resistant dogs had significantly different expression profiles that allowed the software to 
cluster the dogs in the two respective groups. Using the Bonferroni multiple testing 
methods, 49 genes in the liver, 13 genes in heart, and 477 genes in brain were identified 
as being both statistically different (p-value <0.05) and differentially expressed (greater 
than ± 2-fold) . Of these, 48 were up-regulated and 1 down-regulated in the liver; 6 were 
up-regulated and 7 down-regulated in the heart; 326 were up-regulated and 77 down-
regulated in the brain. An abbreviated list of results is listed in Table 3. 
Discussion 
Atherosclerosis has an established polygenic inheritance with environmental risk 
factors playing a large role in the disease progression in humans (Lusis et al. 2004). One 
advantage of the canine model of atherosclerosis is the normalization of environmental 
factors among dogs in the study. Each dog in the study is maintained in the same 
environment, exposed to the same external influences, and fed the same diet – all of 
which are variables contributing to variation of mRNA expression. Thus, differences 
observed between the resistant and sensitive dogs should primarily be due to genetic 
control.   
Complex segregation analysis, developed by Bonney (1986), can clarify the 
mode of transmission by evaluating both single locus transmission and polygenic  
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Table 3: List of differentially expressed genes in pathways known to contribute to 
atherosclerosis development in the liver. Cells containing multiple values represent fold 
changes calculated for several probes from a specific gene.  (*) indicates a significant P-
values (<0.05). 
 
Pathways and Genes Fold change 
Bile Acid Regulation  
Organic anion transporting polypeptide A  5.89 
Organic anion transporting polypeptide C  4.79 
Endothelial Dysfunction  
Endothelial nitric oxide synthase  1.13 
Angiotensinogen  105.0; 17.4 
Angiotensin converting enzyme 2 precursor  6.76 
Cholesterol Biosynthesis  
Mevalonate kinase  2.68; 4.50; 9.15 
Squalene monooxygenase (epoxidase) 0.21; 0.21; 0.26 
Reverse Cholesterol Transport  
ATP-binding cassette protein A1  0.43; 2.78; 8.35 
Scavenger receptor class B type 1  1.41; 16.36 
Nuclear Receptors/Cholesterol Efflux  
Retinoid X receptor beta 6.34 
Thyroid receptor interacting 3 1.10 
Lipoproteins  
Apolipoprotein AV 4.64 
Apolipoprotein L6 10.27 
Apolipoprotein B 0.93 
Apolipoprotein AIII 0.65 
Bile Acid Synthesis  
Cholesterol 7α-hydroxylase 5.42 
Sterol 12 α-hydroxylase 36.95 
CEL and CEL regulation  
Carboxyl ester lipase 0.149* 
ASM-like phosphodiesterase 3.60 
Phospholipase A2 group 1B 2.50 
Cellular Lipid Synthesis and Fatty Acid Degradation  
Acyl-CoA synthetase long-chain family member 1 48.12* 
Acyl-CoA synthetase long-chain family member 5 143.5* 
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inheritance. The sample size used in the present study precluded the use of this 
approach. More dogs and the associated clinical data from the colony will need to be 
collected to determine the inheritance of hypercholesterolemia and atherosclerosis in the 
Lab-mix model. 
Limitations to the use of the threshold model in evaluations of heritability exist, 
and the addition of other dogs or kindred to the studies may alter the results presented 
here. The population structure described herein, however, meet the minimum 
requirements of the threshold model.  The heritability identified for canine 
atherosclerosis in this study (0.55-0.58) is higher than that estimated for the human 
(~0.40). This estimate indicates a significant contribution of genetic factors accounting 
for the phenotypic variation in the population of Lab-mix dogs. 
Because the Lab-mix colony is a closed breeding population with few founders 
and significant inbreeding, the dogs are largely genetically homogeneous. Very few 
differences in gene expression were observed between the two groups in both the liver 
and the heart, two of the most important organs in atherosclerosis. These differences, in 
theory, may be directly related to disease. The statistical approach used in this analysis 
examined only those genes with a statistically significant (<0.05) p-value among dogs in 
the two classes and differentially regulated (>±2-fold change) between the two groups.  
Recent studies evaluating canine gene expression using microarrays have used a lower 
(1.5; 1.6) fold change (Lindberg et al 2007, Maccoux et al. 2007) or only statistically 
significant genes (Clements et al. 2007). Reducing the stringency employed here may 
have allowed the identification of more known atherosclerosis-related genes.  
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Several intriguing genes identified by the oligonucleotide array in sensitive dogs 
include: ACSL5 (143.5-fold up-regulated), ACSL1 (48-fold up-regulated), and CEL (6.7-
fold down-regulated) in the liver, and MMP28 (2.7-fold down-regulated) in the heart. 
CEL (carboxyl ester lipase) is located on CFA09 (HSA9q34) and has both cholesterol 
binding and transfer activites (Hui and Howles 2002). Li and colleagues (1996) describe 
CEL-facilitated reverse cholesterol transport by the delivery of cholesterol from HDL to 
the liver. Additionally, CEL in the vessel walls appears to provide a protective 
mechanism against atherosclerosis development (Hui and Howles 2002).  
ACSL1 is located on CFA16 (HSA4q34-35) and ACSL5 is located on CFA28 
(HSA10q25.1-q25.2). These are involved in the fatty acid metabolism and peroxisome 
proliferator-activated receptor (PPAR) pathways (Rebhan et al. 1997). The identification 
of two differentially regulated paralogs in a single tissue suggests further research in the 
fatty acid and PPAR pathways should be done. MMP28 (CFA09; HSA17q11-q21.1) is 
involved in remodeling and repair of tissues (Rebhan et al. 1997). The differential 
expression of this gene is most likely as a responsive reaction to the vascular injury 
occurring in sensitive dogs, and the inflammatory processes induced by atherosclerosis 
development.  
 The linkage analysis did not yield any statistically significant LOD scores 
(LOD<3). This may be due in part to the small sample size and also to a polygenic mode 
of inheritance. Several linkage studies in murine models have identified QTLs for 
atherosclerosis (Allayee et al. 2003, Smith 2003, Dweyer et al. 2004), and the 
homologous regions in the canine genome were therefore examined.  One marker with a 
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suggestive LOD score (1.24), C11.873, is located on CFA11 in a region sharing 
homology with HSA09 and MMU04. Chromosome 4 in the mouse has an 
atherosclerosis-susceptibility QTL (Wang et al 2003, Korstanje et al. 2004). The 
homologous region in the human is HSA9q31.1. One intriguing gene located in this 
region is ABCA1, a mediator of cholesterol removal from cells by HDL (Lusis et al. 
2004). Another candidate gene identified in this region of the mouse is TLR4 (Wang et al 
2005). TLR4 is an activator of inflammatory cells and regulates both innate and adaptive 
immune responses (Li and Sun 2007). The initiation and progression of atherosclerosis is 
due to inflammation and immune responses (Libby 2002). TLR4 expression has been 
detected in atherosclerotic lesions and is associated with disease progression (Li and Sun 
2007), but the mechanisms by which this occurs is not fully understood.   
A second marker, on CFA05 (CHP14), is located in a region sharing homology 
with HSA16q22.1-21 and MMU08. LCAT encodes a reverse cholesterol transport 
product, and is located at HSA16q22.1-q21. Murine autosome 8 also contains a QTL for 
atherosclerosis corresponding to HSA16q22-24 (Wang et al 2005).  
Both ABCA1 and LCAT were identified as candidate genes from the QTL regions 
of the mouse (Wang et al 2005). The identification of regions harboring these two genes 
suggests the involvement of reverse cholesterol transport (HDL) in the onset of 
atherosclerosis in the Lab-mix. Because HDL is the predominant cholesterol transporter 
in the dog, a defect of the reverse cholesterol transport process (removal of cholesterol 
from tissue to the liver) would prevent cholesterol removal and thus allow the build-up 
of cholesterol in tissues, leading to the development of atheromas.  
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Another explanation for reverse transport-related genes could include excess 
cholesterol accumulation in HDL, leading to atheromas comprised of HDL molecules. 
HDL itself has been shown to be sufficient to induce atherosclerosis when oxidatively 
modified (Carter et al 1987). Histochemical studies to evaluate the composition of 
atherosclerotic plaques would distinguish between the two potential explanations.  
The results from this work suggest that an error in reverse cholesterol transport 
causes cholesterol-sensitivity in the atheromatous dogs, and CEL, ABCA1, and LCAT, 
represent plausible candidates. Even so, it seems quite likely that many false negatives 
were encountered in the linkage analyses due to the high degree of homogeneity in the 
small population. Future studies will include investigation of the three aforementioned 
genes, as well as the addition of more dogs from the colony in order to increase the 
power of the pedigree. Additionally, histopathological studies are planned for the 
comparison of canine atherosclerotic lesions to those found in the human.  
In conclusion, multiple approaches were taken to evaluate the genetics of 
atherosclerosis in the domestic dog. Estimates of heritability, linkage analyses, and gene 
expression analyses were completed for a colony of mixed breed dogs segregating 
atherosclerosis. Atherosclerosis was determined to be a highly heritable trait in the dog. 
The highest LOD scores produced in the linkage analyses, though not statistically 
significant, were found for genomic regions sharing homology with murine QTLs for 
atherosclerosis. The global gene expression profiles revealed a number of genes; some 
have previously described associations with atherosclerosis, and others have yet to be 
studied.   
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CHAPTER III 
HEREDITARY EVALUATION OF MULTIPLE DEVELOPMENTAL 
ABNORMALITIES IN THE HAVANESE DOG BREED* 
 
Overview 
The Havanese is a toy breed that presents with a wide range of developmental 
abnormalities. Skeletal defects, particularly osteochondrodysplasia (CD), are the most 
frequently observed anomalies. Cataracts, liver shunts, heart murmurs, and missing 
incisors are also common in this breed. Estimates of heredity and complex segregation 
analyses were carried out to evaluate modes of transmission for these abnormalities. A 
moderate heritability was identified, and evidence for a single major locus was found. 
Novel statistical analysis methods have identified four traits which co-segregate: 
cataracts, hepatic abnormalities, CD, and cardiac abnormalities. A canine-specific 
microarray was used to identify changes in gene expression in the liver that accompany 
the aforementioned developmental problems. One hundred thirteen genes were found to 
be differentially regulated in the Havanese.  
Introduction 
The Havanese is a toy dog that presents with multiple developmental 
abnormalities. The breed originated in Cuba as an aristocratic pet. In the 1970’s, the  
____________ 
*Reprinted with permission from Starr AN, Famula TR, Markward NJ, Baldwin JV, 
Fowler KD, Klumb DE, Simpson NL, Murphy KE, 2007. Hereditary evaluation of 
multiple developmental abnormalities in the Havanese dog breed. J Hered. 98(5):510-
517. © The American Genetic Association.  
 
 
 27
breed was introduced into the United States and the current US population is reported to 
have developed from four kindred from Cuba, Costa Rica, Russia, and the US. Cataracts, 
retinal detachment, cancer, CD, and premature death were described in the founding 
population. 
Breeders of Havanese are concerned with the extensive abnormalities afflicting 
the breed and began assembling phenotypic data for use in future genetic studies. In 
2004, members of the Havanese Club of America (HCA) created an anonymous owner 
survey, allowing them to quantify the frequency of each abnormality within the breed as 
a whole (J Ruthford, unpublished data). Abnormalities of the forelegs occurred most 
frequently with 44% of the population having bowed, shortened, or asymmetric forelegs. 
Additionally, 7% of dogs had abnormal hips, 5% had luxating patellas (lateral and 
bilateral), and 1% had Legg-Calve-Perthes. Eleven percent of dogs were found to have 
atypical lenses (cataracts of all types and sizes) in the HCA survey, and similarly, a 
retrospective case study of canine cataracts identified the Havanese as having the second 
highest prevalence of cataract (11.57%) among breeds reported in the Veterinary 
Medical Data Base (VMDB) (Gelatt and MacKay 2005).  Six percent of Havanese were 
diagnosed with heart problems; the most common is cardiac murmur (82%), followed by 
mitral valve insufficiency (31%). In an additional case study, Havanese were found to 
have the highest proportion of liver shunts among breeds reported in the VMBD (3.2%) 
(Tobias and Rohrbach 2003). Cryptorchidism occurs in 5% of male dogs. Eighteen 
percent of the dogs in the survey presented with some deviation from normal dentition. 
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Many types of cancer have been described in the breed but estimates of incidences are 
not available.  
In an effort to identify heritable risk factors, we collected detailed phenotypes 
and pedigree information on 253 Havanese. A subset of 122 dogs was chosen to generate 
initial estimates of heritability and to assess disease transmission using complex 
segregation analysis. In addition, the co-occurrence of the diverse abnormalities 
observed in the Havanese was tested to determine whether the spectrum could be 
analyzed as a composite phenotype, drawing on the Rasch family of measurement 
models to construct a syndrome scale (Rasch 1960). 
While statistical approaches are necessary, it is also important to assess the 
underlying genetic changes that either cause the purported syndrome or are in response 
to various clinical abnormalities. Thus, a canine-specific oligonucleotide array was used 
to generate a gene expression profile for affected Havanese and 113 genes were found to 
be differentially regulated. Genes involved in DNA repair, methylation, various 
metabolic, catabolic, and biosynthetic processes, ion transport, cholesterol absorption 
and transport, and skeletal development were among those found to be differentially 
regulated. Described herein are statistical and genetic analyses of anomalies of the 
Havanese.  
Materials and methods 
Assessment of phenotype and analysis 
The initial screen involved the collection of detailed phenotypic data on 122 
Havanese. Pedigree information for an additional 60 animals, including parents and 
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grandparents, was also incorporated, although no phenotypic data were available for 
these dogs. The 182 dogs were assembled into 4 kindred, with 12 additional small, 
unrelated parent-offspring trios. Eleven phenotypes were collected and used to evaluate 
overall disease severity: skeletal (CD), ophthalmic (cataracts), cardiac (murmurs), 
hepatic (liver shunts), pre- and post-prandial bile acid levels, alanine aminotransferase 
(ALT), cholesterol, taurine, height, and weight. Only skeletal, ophthalmic, cardiac, and 
hepatic data were used to evaluate overall clinical status. The only additional variable 
included in the analysis was gender. 
Due to the complex nature of phenotypic variability in the Havanese, two 
systems of overall disease scoring, binary (dichotomous) and multi-categorical 
(polytomous), were implemented to evaluate the transmission of clinically defined traits. 
The dichotomous system categorized dogs as affected if one abnormality was present, 
regardless of severity. This approach yielded two classes of dogs, unaffected and 
affected. The polytomous variable rated dogs based on the severity of clinical 
abnormalities. A distribution of scores from 0 (unaffected) to 3 (severely affected) was 
used to rate the overall health of individual dogs.  
The dichotomous approach allowed the analysis of 25 unaffected and 22 affected 
male dogs and 34 unaffected and 36 affected female dogs with complete data. When 
using the polytomous variable, 25 males were scored as unaffected (score 0), 12 were 
scored in category 1, 6 in category 2, and 4 in category 3. Thirty-four females were 
scored as unaffected (score 0), 17 were scored in category 1, 5 in category 2, and 14 in 
category 3. Thirty-one males and 32 females had an unknown disease status. These 
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unknown dogs are either deceased or not active in the study, preventing any phenotypic 
data from being collected. Seventy-eight male dogs and 102 female dogs comprised the 
Havanese sample in the statistical analyses. 
These more conventional approaches to phenotype development--yielding the 
dichotomous and polytomous variables described above--were complemented by an 
additional step that invoked a Rasch model (Rasch 1960) to construct a Havanese 
“syndrome” scale that simultaneously captures information about the primary phenotype 
of interest and other ordinal (CD, cataract, murmur, liver shunt) and continuous (pre- 
and post-prandial bile acid levels, ALT, cholesterol, taurine, height, weight) traits that 
may be relevant to disease diagnosis and prevention. Rasch models (Andrich 1978, 
Masters 1982, Müller 1987, Rasch 1960, Wright 1999, Wright and Masters 1982, Wright 
and Stone 1979) are frequently encountered in education, psychology, and sociology 
where they are used to develop unidimensional scales of reading ability, 
psychopathology, disability, and other latent traits that are measured using multi-item 
test and survey instruments. Analytical approaches outlined in Bezruczko (2005) were 
drawn on to implement the Rasch partial credit model (Masters 1982) (1) to explore the 
process whereby a composite Havanese phenotype--characterized by a linear, additive, 
and equal-interval metric--can be defined and validated from heterogeneous data 
structures and (2) to demonstrate how Rasch measures, estimated at the level of 
individual dogs, can be used as sufficient statistics in the context of quantitative and 
population genetics. 
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To accomplish these goals, we parameterized the Rasch model in the following 
manner. Given a matrix of N dogs (rows) who were measured on L discrete phenotypes 
(columns), the stochastic relationship between the “syndrome severity” of dog n and the 
“clinical sensitivity” of phenotype i is captured by the equation 
ln[(Pni)/(1 - Pni)] = Bn - Di, 
where 
Bn = ln[(Pn)/(1 - Pn)] 
is the syndrome severity “measure” estimated for dog n, 
Di = ln[(Pi)/(1 - Pi)] 
is the clinical sensitivity “calibration” estimated for phenotype i, and -∞ < Bn, Di < +∞, 
respectively. In the above model, Pn is the relative frequency of disease for dog n 
observed across all L phenotypes, Pi is the relative frequency of disease status recorded 
for phenotype i across all N dogs, and 
Pni = exp(Bn – Di)/[1 + exp(Bn – Di)], 
is dog n’s expected probability of being affected on phenotype i. The Rasch partial credit 
model (Masters 1982) 
Bn – Dik
expands this elementary framework by permitting each phenotype i to have a unique  
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number of severity levels or “steps” k. The model accommodates these differences and 
assures that estimates of dog measures and phenotype calibrations are unbiased by 
heterogeneous unit scales observed in our database. 
Phenotype scores were assigned using the approach described by Perkins and 
Wright (2005) in their study of gout risk factors. Each dichotomous or polytomous 
phenotype was converted to a k-level rating scale (0-k) whose “steps” reflected the 
number of ordinal levels observed in the raw data. In like manner, each continuous 
phenotype was converted to a 10-level rating scale (0-9) whose “steps” were collinear 
with unit increases in the variable’s original metric. The rescored data were then 
submitted to Winsteps® (Linacre 2006), a popular Rasch measurement software 
program, and the syndrome scale (Figure 2) was constructed using the Rasch partial 
credit model and a joint maximum likelihood estimation (JMLE) procedure (Linacre 
2006).  
 
 33
Expected score Mean ( “:” indicates half-score point)  (illustrated by an observed category)
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Figure 2: Wright map of dog measures and phenotype calibrations. The left side of the 
figure maps the distribution of dogs where (.) represents one dog and (#) represents two 
dogs. The right side of the figure illustrates the distribution of phenotypes. Figure 
indicates fewer severely affected dogs are observed than mildly affected dogs, but 
severely affected dogs are more likely to have rare (severe) clinical signs. Phenotype 
abbreviations: ALT – alanine aminotransferase; CARD – heart abnormalities; CHOL – 
cholesterol; DICH – dichotomous score; HEPAT – hepatic abnormalities; OPHTH – 
ophthalmologic abnormalities; POLY – polytomous score; POST.BA – postprandial bile 
acids; PRE.BA – fasted  bile acids. Along vertical axis, T = two standard deviations, S = 
one standard deviation, M = mean. 
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Estimation of heritability 
 Our analysis of disease in the Havanese follows two distinct paths, given the 
nature of the observations recorded. One of the traits was measured as a binary condition 
(unaffected, affected). In addition, a rating scale (0, 1, 2, 3) was utilized to indicate 
disease severity. Although such scores are not guaranteed to follow a normal 
distribution, simulation studies have shown that analyses based on nonlinear threshold 
models provide little improvement in precision over models built upon normally 
distributed residuals when four or more categories are used (Meijering and Gianola 
1985). For this reason, along with the simplicity associated with employing linear 
models for heritability estimation and complex segregation analysis, software that 
evaluates (1) the binary trait in a binary threshold model, and (2) the four-category trait 
as if it has normally distributed residuals was utilized. 
A threshold model for the liability to disease was implemented to estimate the 
heritability of the binary phenotype. The strategy employed is similar to that used in the 
evaluation of Addison’s disease by Oberbauer et al. (2006). Calculations were carried 
out using SOLAR (Almasy and Blangero 1998, Blangero et al. 2005), making use of the 
approach documented by Duggirala et al. (1997). 
The analysis of the polytomous trait followed a similar trajectory without the 
assumptions of an underlying continuous variable and an unobservable set of thresholds. 
This phenotype was treated as a continuous trait, recognizing that the phenotypes of 
related animals would be correlated based on the degree of relatedness and the 
magnitude of the genetic variance. The exact representation of this model can be found 
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in Almasy and Blangero (1998). Although the phenotype is not continuous, the 
simulation work of Meijering and Gianola (1985) suggested that linear models can be 
used to analyze polytomies of 4 or more categories without substantial loss of efficiency. 
SOLAR (Almasy and Blangero 1998, Blangero et. al. 2005) was again employed to 
derive heritability estimates, using a multivariate normal to maximize the likelihood 
(NOTE: SOLAR is capable of accommodating only binary or normally distributed 
phenotypes).  
It should be noted that because the data represent owner submissions, the data 
were collected in a non-random fashion. Moreover, this is a study of inheritance, so the 
data were constructed around probands. Such data typically require some adjustment for 
ascertainment bias. However, the mixed linear models utilized in this study 
accommodate non-randomly sampled data (Henderson 1984) as long as the dogs added 
into the study to complete the pedigree associations can be considered a random sample 
of Havanese. In addition, a test of the effect of gender on the predisposition to disease 
was tested using a likelihood ratio test.  
Complex segregation analysis  
The possibility that the dichotomous disease or the polytomous disease in 
Havanese is influenced by the action of a single segregating locus of large effect can also 
be examined. Complex segregation analysis, developed by Bonney (1986), is intended to 
integrate Mendelian transmission genetics at a single locus with the patterns of 
covariance expected in polygenic inheritance. Lynch and Walsh (1998) provide a more 
complete description of complex segregation analysis and the methods used in this 
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investigation follows that employed in Oberbauer et al. (2006). Elston et al. (1975) 
outlined the criteria that must be satisfied before acceptance of the single major locus 
model so as to reduce the risk of false positive declarations of a major locus model. 
Evaluation of the models necessary for complex segregation analysis was conducted 
with the Bayesian software package iBay (2006, version 1.0). The iBay software is an 
extension of MaGGic (Janss 1998) rewritten to accommodate complex segregation 
analysis in binary traits, as well as normally distributed phenotypes, for pedigrees that 
include inbreeding.  
Note also that the iBay software models the unobservable scale of the binary 
threshold trait such that the residual variance is fixed at 1.0 (i.e., σe2 = 1). In the case of 
the ordered categorical trait, the iBay software evaluates phenotypes under a normal 
distribution (iBay, as does SOLAR, evaluates binary or normally distributed 
phenotypes).  
Creation of the Gibbs sample requires several key assumptions about the 
behavior of these unknown parameters. Though a variety of models can be considered, 
all are some variant of the following: gender as a fixed effect with a flat (i.e., uniform) 
prior density, the polygenic variance component with a flat prior density, as well as flat 
prior densities for the additive, dominance, and allele frequency parameters. A Gibbs 
sample of 5,000 was generated, beginning with the creation of 300,000 total samples, a 
“burn-in” of 50,000 and a sampling rate of every 100-th Gibbs value. This process was 
repeated to create two replicate chains. From the 5,000 Gibbs samples, the mean, 
standard deviation, mode and the upper and lower limits of a 95% highest density region 
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(HDR) was computed for each of the unknown parameters. For the binary trait, iBay 
fixes the residual variance at 1, and allows the polygenic variance to be generated as part 
of the Gibbs sampling process. For the ordered categorical trait, where the phenotype is 
assumed to follow a normal distribution, the residual and polygenic variances are 
generated in the Gibbs sampling process. 
Global gene expression 
The Affymetrix canine genome 2.0 array (Santa Clara, CA) was used to assess 
gene expression in the Havanese. The array contains 42,929 total probe sets (including 
all controls) and includes 18,000 canine specific transcripts and over 20,000 predicted 
gene sequences based on sequence similarity with known genes in other species.  
Three Havanese samples were selected for this study. Two dogs were half-
siblings approximately one year apart in age. The third dog was a puppy selected for her 
medical history. All dogs were affected based on the Havanese grading criteria. Liver 
samples were collected at the time of euthanasia. One dog suffered from metastatic lung 
disease, mitral valve insufficiency, and CD, another suffered from severe CD, and the 
third, the puppy, had a suspected liver shunt and lung abnormalities noted in the 
necropsy. These dogs were euthanized by their respective veterinarians. Tissue was 
stored in RNAlater® (Ambion, Austin, TX). Because these are client-owned dogs, age-
matched normal Havanese were not available. Tissues from three clinically normal 
mixed-breed dogs were used as normal controls. These dogs displayed none of the 
abnormalities appearing in the Havanese and were determined to be clinically normal by 
standard blood chemistry panels and detailed physical exams. 
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RNA isolated from the liver was prepared by Viagen Inc. for hybridization to the 
Affymetrix canine 2.0 array using the classic protocol (Chomczynski and Sacchi 1987). 
Ambion’s linear amplification kit, MessageAmpTM aRNA Kit (Ambion Inc.), was used 
for first-strand cDNA, second-strand cDNA, and biotin labeled cRNA synthesis. Two 
micrograms of total RNA were used to start the single round of amplification. Duplicate 
experiments were performed for all samples. Fragmentation of the labeled cRNA was 
performed as follows: incubation at 95˚C for 35 minutes in a solution containing 40mM 
Tris-acetate (pH 8.1), 100mM KOAc, and 30mM MgOAc. Forty micrograms of the 
fragmented, labeled cRNA was then hybridized to each of the GeneChip® (Affymetrix) 
oligonucleotide arrays. These arrays were washed, stained, and scanned in accordance 
with a previously published protocol (Ji et al. 2004).  
High-resolution GeneChip images were collected on the GeneChip Scanner 3000. 
Affymetrix GeneChip operating software was used to quantify image data and calculate 
gene expression values.  
GeneSpring software (Silicon Genetics, Redwood City, CA) was used to perform 
gene clustering, Students’ t-test, and Bonferroni multiple testing corrections. Samples 
were grouped separately to identify differentially expressed genes. Gene expression 
ratios were calculated between the two groups.  
Results 
Estimation of heritability 
Estimates of heritability of 0.36 (± 0.27) for the dichotomous disease and 0.36 (± 
0.16) for the polytomous disease support a moderate hereditary component and suggest 
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the clinical disease described herein may have a hereditary component (Table 4). No 
difference in risk between gender was observed (data not presented).  
 
 
Table 4: Estimate of heritability in a threshold model for the dichotomous and 
polytomous disease. 
 Estimate Standard Error p-value 
Dichotomous 0.359 0.27 0.026 
Polytomous 0.358 0.16 0.0016 
 
 
 
Complex segregation analysis 
The results of the complex segregation analysis provide no conclusive evidence 
for the action of a single major locus influencing the dichotomous disease trait (data not 
presented). However, the results of the complex segregation analysis for the polytomous 
disease trait do provide evidence for the action of a single major locus (Table 5). For all 
parameters of interest, the 95% highest density region (HDR) does include zero, a clear 
demonstration that the actions of a major locus for this disease in the Havanese are 
supported. Not presented is the equivalent analysis accommodating non-Mendelian 
transmission of the putative major allele. Such an analysis is one of the criteria 
established by Elston et al. (1975) when considering the action of a major locus. When 
evaluated through the 95% HDR, overlap with Mendelian transmission estimates were 
demonstrated, indicating the Mendelian model provides the best fit to the data.
40
 
 
 
 
 
 
 
 
 
Table 5: Marginal posterior means, modes, standard deviations and limits to the 95% highest density regions of model 
parameters for the polytomous score in Havanese in a Bayesian mixed-inheritance model with a completely recessive major 
locus. 
 Residual
Variance 
 Polygenic 
Variance 
Major Locus 
Variance 
Additive 
Effect (a) 
Dominance 
Deviation (d) 
Frequency 
(q) 
Mean 0.29 0.06    0.82 1.10 -1.10 0.46
Mode 0.28      
      
      
      
0.01 1.65 1.07 -1.15 0.42
SD 0.06 0.06 0.22 0.08 0.08 0.07
HDR 95% Low 0.08 0.00 0.31 0.88 -1.34 0.22
HDR 95% High 0.59 0.61 1.74 1.39 -0.83 0.73
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The Havanese syndrome scale 
The Rasch analysis yielded linear measures, standard errors, and model fit 
statistics for each dog and phenotype included in the analysis (not presented). Average 
Outfit and Infit mean-square statistics (Bond and Fox 2001, Wright 1984, Wright and 
Masters 1981) were satisfactory for dogs (Infit = 0.99, Outfit = 0.90) and phenotypes 
(Infit = 1.00, Outfit = 0.96), lending provisional support of the scale’s specific (local) 
objectivity and validity as a unidimensional “yardstick” of Havanese trait variation. 
Figure 2 illustrates the relative distributions of dog measures (left) and phenotype 
calibrations (right) along the range of measurement. 
The common unit of the scale allows interpretation of the relationship between 
dogs and phenotypes with ease and clarity: dogs with higher measures are more likely to 
be affected with the syndrome than dogs with lower measures, and phenotypes with 
higher calibrations are less sensitive to clinical detection, generally speaking, than 
phenotypes with lower calibrations. The Rasch model unifies these two distances in the 
following manner: Dogs with higher measures are 1) more likely to be affected on 
phenotypes whose sensitivity calibrations reside below his or her position on the scale; 
2) less likely to be affected on phenotypes whose calibrations reside above his or her 
position on the scale; and 3) equally likely to be affected on phenotypes whose 
calibrations reside at his or her position on the scale. The mean (M) and standard 
deviation (S = 1 SD, T = 2 SD) of dog measures are indicated by “TSMST,” 
respectively. 
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 Figure 3 depicts how a breeder might implement these principles in practice. The 
logit range at the top and bottom of the graphic is the measurement continuum. 
Phenotypes are documented to the far right with the same abbreviations listed in Figure 
2, and the numbers in the body of the table are the phenotype categories described 
previously. The colon (:) between each pair of adjacent categories indicates the point on 
the measurement scale at which a dog whose estimated measure falls at the location has 
an equal (50/50) probability of being classified in the lower or upper category. For 
example, the expected probability of disease (DICH) for a dog with a measure of -1.00 is 
0.50. 
Global gene expression using microarray 
A canine-specific oligonucleotide array was used to create a disease expression 
profile. The profiles displayed significantly different expression patterns such that 
normal and affected dogs clustered into their respective groups. Under the most stringent 
statistical parameters, 113 genes were identified as being differentially expressed in 
liver, with a greater than two-fold difference in expression and a p-value ≤0.05. Of these, 
83 were down-regulated and 30 were up-regulated (abbreviated results in Table 6).  
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Figure 3: Illustration of the expected score means. Each trait has the categorical score 
distribution along the horizontal axis. A (:) indicates a half-score point for an observed 
category. Abbreviations used are the same as in Figure 2. 
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Table 6: List of differentially regulated genes identified by the gene expression assay. 
Affymetrix probe names were searched in the NetAffx analysis center to identify the 
canine locus name (Dog LOC). A search in Gene Cards (http://www.genecards.org/) 
using Dog LOC identified the orthologous human loci or genes. The list presented 
includes only those probes that identified gene orthologs. (Adapted from Starr et al. 
2007) 
  
Gene Dog LOC 
Fold 
Change  P-Value Location Probe Name 
HELLS LOC486809 0.143 0.047 28 CfaAffx.12909.1.S1_at 
MGAM  LOC475523 0.168 0.0117 16 CfaAffx.6714.1.S1_at 
NQO1 LOC610935 0.186 0.00109 5 CfaAffx.31023.1.S1_at 
PKP4 LOC478759 0.191 0.0102 36 Cfa.3365.1.A1_at 
OXCT1 LOC479347 0.194 0.00597 4 Cfa.10153.1.S1_at 
ABCG8 LOC474571 0.219 0.00299 10 Cfa.7435.1.A1_at 
EPHX1 LOC480113 0.234 0.00133 7 CfaAffx.24797.1.S1_at 
EPHX1 LOC480113 0.241 0.00925 7 Cfa.4088.1.A1_at 
C5orf4 LOC489163 0.244 0.000264 4 Cfa.12428.1.A1_at 
CXCL12 CXCL12  0.251 0.0156  Cfa.20779.1.S1_at 
PHKA2 LOC480857 0.251 0.00396 X Cfa.5653.1.A1_at 
EPHX1 LOC480113 0.256 0.00471 7 Cfa.4088.1.A1_s_at 
PKLR PKLR 0.257 0.0467 7 Cfa.8012.1.A1_at 
C10orf59 LOC610448 0.258 0.00505 26 Cfa.12560.1.A1_at 
NQO1 LOC610935 0.278 0.000742 5 Cfa.16827.1.A1_at 
PKP4 LOC478759 0.281 0.00054 36 Cfa.3365.1.A1_s_at 
KCNN2 LOC474640 0.289 0.00289 11 Cfa.5095.1.A1_s_at 
C1orf32 LOC490364 0.291 0.0176 7 Cfa.9794.1.A1_at 
LTB4DH LOC474802 0.297 0.0332 11 Cfa.12192.1.A1_s_at 
SPHK2 LOC484401 0.313 0.00947 1 Cfa.1378.1.A1_at 
HTATIP2 LOC476886 0.315 0.00544 21 Cfa.3269.1.S1_at 
ALDH7A1 LOC481486 0.342 0.0478 11 Cfa.15706.1.A1_at 
CRYL1 LOC486050 0.344 0.0243 25 Cfa.4354.1.S1_a_at 
MFAP3L LOC477356 0.346 0.00988 25 Cfa.21163.1.S1_s_at 
SMARCA1 LOC481046 0.347 0.0231 X Cfa.1931.1.A1_at 
ESD LOC607116 0.349 0.00273 22 Cfa.15993.1.S1_at 
NDUFV1 LOC476004 0.384 0.0348 18 CfaAffx.17348.1.S1_at 
LOC341392 LOC479821 0.398 0.0111 6 Cfa.13263.1.A1_s_at 
NRXN1 LOC474589 0.400 0.00133 10 Cfa.7236.1.A1_s_at 
SMARCA2 LOC476335 0.401 0.0126 1 CfaAffx.3959.1.S1_s_at 
MFAP3L LOC477356 0.401 0.0141 25 CfaAffx.12367.1.S1_at 
LOC341392 LOC479821 0.408 0.00963 6 CfaAffx.27532.1.S1_at 
ABCG5 LOC481354 0.414 0.00491 10 CfaAffx.4636.1.S1_at 
GCLM LOC612283 0.422 0.0287 6 CfaAffx.30811.1.S1_s_at 
EXOC2 LOC478696 0.422 0.00209 35 CfaAffx.14491.1.S1_at 
DST DST 0.424 0.00148  CfaAffx.4509.1.S1_s_at 
CD59 LOC475945 0.429 0.00901 18 Cfa.838.1.A1_at 
TMEM135 LOC607444 0.431 0.0112 21 Cfa.19775.1.S1_at 
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Table 6 continued 
Gene Dog LOC 
Fold 
Change  P-Value Location Probe Name 
FYCO1 LOC476649 0.440 0.0434 20 Cfa.10325.1.A1_at 
C6orf192 LOC611318 0.444 0.0173 1 Cfa.2541.1.A1_at 
DST DST 0.444 0.00938  Cfa.557.1.A2_at 
AGXT2L2 LOC481448 0.448 0.047 11 Cfa.2854.1.S1_at 
TYMS LOC476100 0.463 0.00166 19 Cfa.9380.1.A1_at 
THEM2 LOC610883 0.463 0.00276 35 Cfa.15345.1.S1_at 
AHCYL1 LOC611790 0.472 0.00118 6 Cfa.21135.1.S1_at 
EPB41L4B LOC474797 0.473 0.0221 11 Cfa.14183.1.A1_at 
HEBP1 LOC477690 0.494 0.0284 27 Cfa.12157.1.A1_at 
RETSAT LOC483083 0.499 0.00395 17 Cfa.8888.1.A1_at 
ADRBK2 LOC486327 0.500 0.0202 26 Cfa.8027.1.A1_at 
BCL2A1 LOC488770 2.029 0.00796 3 Cfa.21056.1.S1_at 
RABGEF1 LOC479706 2.287 0.0252 6 CfaAffx.16844.1.S1_at 
RPS6KA3 LOC491768 2.578 0.0375 X Cfa.19022.1.S1_s_at 
SSR1 SSR1 2.760 0.000788 35 CfaAffx.14997.1.S1_s_at 
FGG LOC475474 2.780 0.00583 15 Cfa.13273.1.A1_x_at 
TM6SF2 LOC609715 2.883 0.025 20 CfaAffx.22123.1.S1_s_at 
TM9SF1 LOC480261 3.108 0.0207 8 Cfa.18439.1.S1_s_at 
SEPX1 LOC611032 3.150 0.0368 6 Cfa.12212.1.A1_at 
DDX3X LOC480886 3.181 0.0315 X CfaAffx.22006.1.S1_at 
C12orf23 LOC610769 3.863 0.0224 10 CfaAffx.3602.1.S1_at 
FCN1 LOC608247 3.996 0.0374 9 Cfa.13207.1.A1_s_at 
MAN1A1 LOC476275 4.014 0.0187 1 CfaAffx.2332.1.S1_s_at 
STAT3 LOC490967 4.061 0.0154 9 Cfa.5199.1.A1_at 
FAM107A LOC607380 4.067 0.00242 20 Cfa.18258.1.S1_at 
HN1 HN1 4.358 0.00138 9 CfaAffx.8018.1.S1_s_at 
PGM3 LOC474981 5.628 0.0227 12 Cfa.20949.1.S1_s_at 
MUT LOC474930 5.650 0.00145 12 Cfa.19060.1.S1_s_at 
ALPL ALPL 6.756 0.0179 2 CfaAffx.22870.1.S1_s_at 
DNAJC3 LOC476966 7.770 0.0256 22 Cfa.7822.1.A1_s_at 
SPINK2 LOC611439 7.796 0.0124 13 Cfa.11889.1.A1_at 
SLC16A7 LOC481138 7.861 0.0376 10 CfaAffx.1420.1.S1_at 
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Discussion 
Havanese are afflicted with multiple developmental abnormalities, most 
frequently CD, cataracts, heart murmurs, and missing incisors. This initial investigation 
of the breed has yielded intriguing results. Estimates of heritability calculated for the 
data set support the possibility that this collection of multi-organ abnormalities is 
inherited as a single disease. Complex segregation analyses support a major locus model 
under the polytomous scoring method.  
Affected Havanese present with variable phenotypes. Initial phenotype scoring 
utilized a binary system which yielded an estimate of heritability of 0.36, supporting the 
hypothesis that this cluster of phenotypes has a hereditary basis. Segregation analysis did 
not elucidate a mode of transmission or even provide evidence for a major locus. When 
dogs were re-evaluated using a multi-categorical scoring system, we obtained the same 
estimate of heritability and evidence to support the existence of a major locus. 
Penetrance and expressivity could provide a plausible explanation for the inconsistent 
disease presentation.  
The heritability value of 0.36 indicates a moderate genetic contribution to disease 
variability. Low levels of genetic variance or an inability to detect all genetic variance 
may contribute to this modest estimate. The introduction of unrelated dogs into the 
kindred of Havanese from this study may increase the genetic variance in the population 
and therefore increase the heritability. In a small population such as the Havanese, which 
ranked 38th in American Kennel Club registration in 2006 (American Kennel Club 
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2007), low genetic variance is expected due to the small number of founders and popular 
sires.  
The identification of CD as a variable that co-segregates with the hypothesized 
syndrome, coupled with the alignment of the CD and DICH thresholds in Figure 3, 
suggests the benefit of using CD as a physiological marker for disease. Dogs categorized 
as CD are more likely to have other abnormalities; therefore, the CD phenotype may be 
useful in predicting the overall health of an individual for breeding purposes. A 
standardized evaluation of antebrachial conformation could provide objective measures 
of forelimb shortening, bowing, or asymmetry.  
The Rasch analysis provided a first, imperfect glimpse of how these tasks might 
be accomplished in practice. The measurement properties and clinical validity/utility of 
the syndrome scale have yet to be assessed in a truly rigorous manner; however, this 
analytical approach is useful for integrating heterogeneous clinical data and may 
facilitate the development of a robust phenotype that better serves researchers and 
breeders. Future studies will be concerned with these and related questions, as well as 
the potential of incorporating genetic information in the scale construction process 
(Markward 2004, Markward and Fisher 2004). 
The clinical signs described in the Havanese are similar to signs characteristic of 
many human syndromes. This prohibits the use of a candidate gene approach to dissect 
the underlying genetics. While there are similarities between various human diseases and 
the signs in the Havanese, there are not any human syndromes that capture the complete 
spectrum of Havanese abnormalities. Thus, in order to develop a genetic profile for the 
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Havanese, an oligonucleotide array was used to identify gene expression differences 
between affected and normal Havanese. Hepatic tissues were used in this experiment 
with the goal being to delineate genetic biomarkers important in the disease process. The 
liver was chosen because of the inclusion of hepatic abnormalities in the overall 
syndrome. Future studies may include use of other tissues to create a better spectrum of 
gene expression profiles across affected tissues. The differentially regulated genes 
identified are involved in DNA repair, methylation, various metabolic, catabolic, and 
biosynthetic processes, ion transport, cholesterol absorption and transport, and skeletal 
development, among other processes (Rebhan et al. 1997). Genes of particular interest 
include ABCG8 (4.5-fold down-regulated), ABCG5 (2.4-fold down-regulated), and 
ALPL (6.8-fold up-regulated) (Table S1).  
ABCG5 and ABCG8 encode a heterodimer (Berge et al. 2000) instrumental in the 
absorption and transport of dietary cholesterol, as well as in sterol excretion into bile 
(Rebhan et al. 1997, Klett et al. 2004, Oram and Vaughan 2006). Both genes are 
members of the ATP-binding cassette family, sub-family G (Rebhan et al. 1997). In the 
human, defects in either of these genes cause sitosterolemia (MIM 210250), an 
autosomal recessive disorder characterized by increased absorption of all sterols 
(Bhattacharyya and Connor 1974, Beaty et al. 1986). The increased absorption results in 
hypercholesterolemia and high plasma levels of plant sterols, which leads to 
atherosclerosis and coronary artery disease in man (Berge et al. 2000). The role these 
two genes play in canine hepatocytes has not been directly investigated.  
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Reduced expression of ABCG5 and ABCG8 in affected Havanese may indicate a 
coordinated response to reduce absorption of sterols by enterocytes as well as increase 
hepatobiliary secretion of cholesterol. Alternatively, expression levels of ABCG5 and 
ABCG8 may be a reflection of a mutation affecting the normal function of the 
heterodimer. It is plausible that both ABCG5 and ABCG8 are down-regulated in response 
to some abnormality in the cholesterol biosynthesis or metabolism pathways. The dog 
has long been recognized as a species extremely efficient at regulating cholesterol levels 
(Abell et al. 1956, Pertsemlidis et al. 1973): dogs compensate for increased dietary sterol 
absorption by increasing excreted cholesterol and bile acids and/or by inhibiting 
cholesterol biosynthesis. Thus, it would follow that a decrease in sterol absorption would 
increase cholesterol biosynthesis or decrease excreted cholesterol and bile acids.  
ALPL presents an interesting potential candidate gene for the disease in the 
Havanese. Mutations in ALPL cause hypophosphatasia (MIM 146300, 241500, 241510), 
an inherited condition with variable clinical expression affecting skeletal ossification and 
mineralization (Whyte 1994). The skeletal abnormalities of hypophosphatasia result 
from impaired activity of alkaline phosphatase liver/bone/kidney (Weiss et al. 1988, 
Henthorn et al. 1992). There are five forms of hypophosphatasia in humans: perinatal 
(lethal), infantile, child, adult, and odontohypophosphatasia (reviewed in Whyte 1994 
and Mornet 2000). The transmission of hypophosphatasia is generally reported as 
autosomal recessive, though isolated families have an autosomal dominant form 
(Danovitch et al. 1968, Bixler et al. 1974, Moore et al. 1999, Hu et al. 2000). Improperly 
ossified or mineralized bones, specifically the weight-bearing bones in the limbs, can 
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result in a bowed morphology (Sergi et al. 2001). The clinical signs of 
odontohypophosphatasia mimic the primary signs in the Havanese: skeletal defects and 
abnormal dentition. Secondary genes would be expected to contribute to the organ 
abnormalities since mutations in ALPL have clinical manifestations limited to skeletal 
and dental anomalies.  
In addition to its role in skeletal development, ALPL is also involved in folate 
biosynthesis (Rebhan et al. 1997). Folate is a naturally occurring B-vitamin important in 
many biological processes, including DNA synthesis and repair and neural tube 
formation (Kelemen 2006, Blom et al. 2006). Down-regulation of another gene involved 
in folate biosynthesis, SMARCA2 (2.5-fold) (Table S1) suggests that further research into 
folate and folic acid (synthetic form of folate) is prudent.  
 In summary, a bipartite approach of statistical evaluation and global gene 
expression profiling was completed to study the complex developmental disease in the 
Havanese breed. The data presented herein establish the disease in the Havanese as an 
inherited condition. Future studies include (1) creating an objective antebrachial 
conformation measure for CD to identify dogs at risk of disease, (2) collecting and 
analyzing serological and hematological data for each dog in the study to look for 
segregation with the diseased phenotype, and (3) evaluating candidate genes identified 
by this study through sequencing and linkage analyses. 
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CHAPTER IV 
CHROMOSOME-SPECIFIC LINKAGE ANALYSES OF DEVELOPMENTAL 
ABNORMALITIES IN THE HAVANESE DOG BREED 
 
Overview 
The Havanese is a toy breed that experiences a high incidence of developmental 
abnormalities including osteochondrodysplasia (CD), cataracts, heart murmurs, and liver 
shunts. Affected dogs present with a variable phenotype. In a previous study, complex 
segregation analysis suggested an autosomal recessive mode of inheritance for the 
collection of abnormalities. Because of the similarity of the Havanese abnormalities with 
human syndromes of disrupted cholesterol biosynthesis, a partial genome screen was 
carried out to examine regions of the genome known to harbor cholesterol biosynthesis-
related genes. No evidence for linkage was obtained in this partial screen, thus future 
work will include completion of a whole genome screen in an effort to identify the major 
locus.  
Introduction 
The Havanese, the national dog of Cuba and part of the Bichon family, is a toy 
breed recognized by the American Kennel Club (AKC) in 1999. A complete and 
thorough account of the history of the breed is not available, but descriptions of the 
breed date back to the 1700s - known then as the Blanquito de la Cubano (White Cuban), 
the Dog of Havana, or the Havana Silk Dog (Klumb and Baldwin 2005).  
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Four primary populations existed in the late twentieth century: Cuban, Costa 
Rican, American, and Russian/Western European. A large percentage of the modern 
American population of Havanese is descended from 8 foundation dogs. These dogs 
were the founders of the AKC stud book and the offspring of nine pedigreed dogs 
obtained by the first Havanese breeder in the United States. Since then, European 
Havanese have been imported to increase genetic diversity of the breed. 
The collection of abnormalities present in the Havanese is thought to be inherited 
in a syndrome-like fashion, in which four abnormalities co-segregate: CD, heart and eye 
abnormalities, and liver shunts (Starr et al. 2007). Starr et al. carried out complex 
segregation analyses which suggested an autosomal recessive mode of inheritance and 
provided evidence for the action of a major locus for the syndrome-like phenotype.  
The involvement of the cholesterol biosynthetic pathway in the Havanese 
abnormalities presents an intriguing possibility. Inborn errors of cholesterol biosynthesis 
result in abnormalities affecting multiple organ systems – primarily skeletal, ocular, 
cerebral, oral, integumentary, cardiac, renal, and genital defects (reviewed in Nowaczyk 
and Waye 2001, Andersson 2002, Herman 2003). Cholesterol biosynthesis disorders 
include Smith-Lemli-Opitz syndrome (SLOS, MIM#270400), desmosterolosis 
(MIM#602398), X-linked chondrodysplasia punctata (CDPX2, MIM#302960), 
congenital hemidysplasia icthyosiform erythroderma limb defects syndrome (CHILD 
syndrome, MIM#308050), lathosterolosis (MIM#607330), and hydrops-ectopic 
calcification-moth-eaten skeletal dysplasia (HEM dysplasia, MIM#215140). These 
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syndromes have been extensively studied, and are disorders characterized by various 
malformations. 
Genome screens are widely utilized to narrow the search for candidate genes 
(Acland et al.1999, Clark et al. 2005a, Clark et al. 2005b). The minimal screening set 2 
(MSS-2) is a comprehensive set of 327 microsatellite markers which offer an average 9 
Mb coverage of each canine chromosome. The MSS-2 is well-suited for completing 
partial genome screens because the markers were multiplexed in chromosome-specific 
fashion (Clark et al. 2004). A multiplex-specific approach was used to evaluate regions 
harboring genes of interest which were identified by the oligonucleotide array (see 
Chapter III), developmental genes, and genes involved in cholesterol biosynthesis.  
From a gene expression profile of the Havanese disease using an oligonucleotide 
array, three genes of interest were identified: ALPL, ABCG5, and ABCG8. Candidate 
genes in similar diseases (which do not encompass the entire spectrum of Havanese 
abnormalities) include COL2A1 (Ocular-skeletal dysplasia) (Du et al. 2000, Meredith et 
al. 2007), COL10A1 (chondrodysplasia) (Young et al. 2006), FGFR1, FGFR2, FGFR3 
(multiple limb malformations) (Wilkie et al 2002). No obvious candidate genes related 
to cardiac and hepatic abnormalities exist, due to the numerous pathways contributing to 
development of organs and the entire cardiovascular system. Unfortunately, hematology 
and serum chemistry panels have been examined in only a few studies of canine skeletal 
dysplasias (Fletch et al. 1973, Terpin and Roach 1981) to determine whether biological 
markers were associated with disease.  
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Materials and methods 
Phenotypes 
Dogs included in the study were examined by their respective veterinarians; 
blood was collected for a serum liver chemistry panel (SA320) and a complete blood 
count (CBC) (Antech Diagnostics, Lake Success, NY). Height and weight measurements 
were collected from all dogs. One overall score was used to evaluate the collection of 
signs and was designated 0, 1, 2, or 3 (unaffected, mild, moderate, or severe), using the 
scoring system developed by Starr et al. (2007). The possibility that additional 
phenotypes were segregating independently from the overall phenotype was evaluated 
using a binary score of affected or unaffected for CD and heart abnormalities.  
Hematology and serum chemistry panels 
Venous blood samples were collected for 97 dogs by each animal's attending 
veterinarian. Whole, serum-separated, and pre- (p-) and post-prandial (pp-) blood 
samples were submitted to Antech Diagnostics according to the diagnostic center’s 
protocol (SA320, Antech Diagnostics) for determination of CBC, serum chemistries, and 
p- and pp-bile acid levels.  
Dogs were grouped by forelimb status (normal or CD) or by overall disease 
status. For each group, 17 biomarkers were evaluated: glucose (GLU), blood urea 
nitrogen (BUN), total protein (TP), albumin (ALB), bilirubin (BILI), alkaline 
phosphatase (ALKP), alanine aminotransferase (ALT), aspartate aminotransferase 
(AST), globulin (GLOB), gamma glutamyltransferase (GGT), hemoglobin (Hgb), 
hematocrit (Hct),  white blood cell (WBC), red blood cell (RBC), mean corpuscular 
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volume (MCV),  mean corpuscular hemoglobin (MCH), and mean corpuscular 
hemoglobin concentration (MCHC). 
Chemistry and hematology results were analyzed in two complementary ways. 
Firstly, analysis-of-variance (ANOVA) and F-tests were implemented to compare the 
raw (continuous) biomarker values of affected and unaffected dogs. Secondly, chi-
squared tests were conducted to test for association between disease status and each 
biomarker after it had been classified into two-category (normal, abnormal) and three-
category (low, normal, high) classification variables using the canine reference ranges 
described in The Merck Veterinary Manual (8th Ed.). 
Linkage 
Buccal epithelial cells were collected from 122 dogs for DNA extraction using 
the Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN).  
The forward primers were labeled with one of four fluorescent dyes and PCR was 
completed as described in Clark et al. (2004), modified for the use of robotics (Bio-Tek 
Precision 2000, Winooski, VT): Stocks of DNA were maintained at 12.5 ng/µl, 4 µl of 
DNA was added for a total of 50ng of DNA to each reaction, and no ddH2O was added 
to the reaction. PCR products were resolved on an ABI 3130 sequencer (Applied 
Biosystems, Foster City, CA) with an internal size standard (Gene Scan 500 LIZ, 
Applied Biosystems). Genotypes for all dogs were assigned using Genemapper® 
software v3.7 (Applied Biosystems). Data were collected for 20 chromosomes which 
harbored candidate genes (Table 7).  
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Table 7: List of candidate genes investigated in the Havanese study. (*) indicates genes 
identified by microarray analysis (Starr et al. 2007). 
 
Candidate 
Genes 
Canine 
Chromosome 
Disorder/Condition (reference or MIM#)
SMARCA2* 1  -- 
ALPL* 2 Hypophosphatasia  (146300,241500, 241510) 
FGFR3 3 Achondroplasia (100800),  hypochondroplasia (146000) 
FGF10 4 lacrimo-auriculo-dento-digital syndrome  (LADD syndrome)(149730) 
DHCR24 5 Desmosterolosis (602398) 
SC5DL 5 Lathosterolosis (607330) 
ABCG5* 10 Sitosterolemia (210250) 
ABCG8* 10 Sitosterolemia (210250) 
SC4MOL 15 Cholesterol biosynthesis 
IGF1 15 Height (Sutter et al. 2007) 
SHH 16 Embryonic patterning (600725) 
FGFR1 16 Kallmann syndrome (147950) 
DHCR7 18 SLOS (270400) 
FDFT1 25 Cholesterol-related cataracts (Mori et al. 2006) 
DHH 27 Embryonic patterning (605423) 
COL2A1 27 Stickler syndrome, type 1 (108300) 
FGFR2 28 Limb growth (Arman et al 1999) 
LSS 31 Cholesterol-related cataracts (Mori et al. 2006) 
IHH 37 Embryonic skeletal patterning (600726) 
HSD17B7 38 Cholesterol biosynthesis 
 
 
Two-point LOD scores were calculated using the Sequential Oligogenic Linkage 
Analysis Routines (SOLAR) software package version 2.1.5 (Almasy and Blangero 
1998). For analysis, each pedigree member was assigned a score for each trait as 
described in the above section. The traits used in the analysis were: composite score, 
CD, Heart, Cholesterol, Height, and Weight.  
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Results 
 The Havanese kindred had an average F value of 0.011 (n=122). The average 
values for serum chemistries and CBCs in normal and CD Havanese are listed in Table 
8. No significant p-values were obtained in the comparison of mean values between 
normal and CD dogs.  
 
 
 
Table 8: The average levels from hematology and serum chemistries, and calculated p-
values between normal and CD Havanese.  
 
Parameter Normal dogs CD dogs p-value 
Glu (mg/dL) 94.28 ± 19.33 91.97 ± 21.48 0.606 
BUN (mg/dL) 16.23 ± 4.53 15.00 ± 3.31 0.135 
TP (g/dL) 6.26 ± 0.53 6.26 ± 0.45 0.998 
Alb (g/dL) 3.52 ± 0.38  3.54 ± 0.34 0.713 
Tbili (mg/dL) 0.14 ± 0.08 0.15 ± 0.08 0.375 
AlkPhos (u/L) 49.50 ± 59.42 34.79 ± 24.34  0.119 
ALT (u/L) 67.08 ± 67.91 58.38 ± 58.56 0.516 
AST (u/L) 29.19 ± 12.68 33.47 ± 26.98 0.389 
Glob (g/dL) 2.74 ± 0.53 2.72 ± 0.33 0.790 
GGT (u/L) 6.02 ± 2.42 6.46 ± 3.28 0.506 
Hgb (g/dL) 15.93 ± 1.86 16.47 ± 1.39 0.176 
Hct (%) 46.93 ± 7.70 49.62 ± 4.15 0.106 
WBC (103/uL) 11.43 ± 9.48 9.71 ± 2.58 0.206 
RBC (106/uL) 6.93 ± 2.47 6.80 ± 0.57 0.754 
MCV 71.58 ± 6.59 72.92 ± 4.04 0.284 
MCH 24.35 ± 0.96 24.21 ± 0.84 0.507 
MCHC 33.78 ± 1.88 33.32 ± 1.99 0.347 
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Tables 9 and 10 provide the data for two Chi-square analyses of the overall 
disease score using classified continuous data: normal vs. abnormal and 
low/normal/high, based on the reference ranges identified by The Merck Veterinary 
Manual. Not presented is the analysis of overall disease using continuous data because 
no significant p-values were obtained.  
 
 
 
 
Table 9: Chi-square analysis of 17 parameters in overall disease phenotype, using the 
low/normal/high scoring system. (*) indicates p-value<0.10, (**) indicates p-
value<0.05. 
 
Phenotype Value DF1 p-value 
GLU 1.4536 3 0.693 
BUN 2.2989 3 0.5127 
TP 12.5507 6 0.0508* 
ALB 1.5024 6 0.9593 
BILI N/A N/A N/A 
ALKP 5.4905 6 0.4826 
ALT 4.1797 6 0.6524 
AST 9.8017 6 0.1333 
GLOB 2.8722 6 0.8247 
GGT 2.3501 3 0.503 
Hgb 2.7987 6 0.8337 
Hct 11.325 6 0.0788* 
WBC 2.0411 6 0.9159 
RBC 3.1124 3 0.3746 
MCV 8.6250 6 0.1958 
MCH 4.7981 3 0.1872 
MCHC 14.5756 6 0.0238** 
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Table 10: Chi-square analysis of 17 parameters in overall disease phenotype, using the 
normal/abnormal scoring system. (*) indicates p-value<0.10, (**) indicates p-
value<0.05. 
 
Phenotype Value DF1 p-value 
GLU 6.8593 3 0.0765* 
BUN 1.7050 3 0.6358 
TP 1.6661 3 0.6445 
ALB 1.1580 3 0.7631 
BILI 2.8934 3 0.4084 
ALKP 3.3820 3 0.3364 
ALT 2.5430 3 0.4676 
AST 1.9099 3 0.5913 
GLOB 2.2955 3 0.5134 
GGT 3.1643 3 0.3670 
Hgb 2.1127 3 0.5494 
Hct 3.3011 3 0.3475 
WBC 3.3989 3 0.3341 
RBC 1.0681 3 0.7848 
MCV 6.6964 3 0.0822* 
MCH N/A N/A N/A 
MCHC 0.5172 3 0.9151 
 
 
 
 
One hundred twenty-one Havanese were genotyped for 114 microsatellite 
markers located on 21 chromosomes. Maximum LOD scores for the composite (overall) 
score, CD, Heart, and Height traits are listed in Table 11. The maximum LOD scores for 
the Cholesterol and Weight traits were 0.38 and 0.62, for marker FH2324 (CFA25) and 
C03.629 (CFA03), respectively (data not shown). 
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Table 11: List of markers identified as having LOD scores >0.90 for the traits composite 
phenotype, CD, heart, and height.  
 
Trait LOD Marker Chromosome
0.98 FH2613 CFA02 
1.34 FH3210 CFA02 
1.25 FH3115 CFA03 
1.66 FH3320 CFA05 
1.09 C10.16 CFA10 
1.10 FH2155 CFA16 
1.60 FH2441 CFA21 
Composite 
phenotype 
0.98 REN02C20 CFA38 
1.33 REN72K15 CFA27 
1.49 REN118L14 CFA27 
1.36 FH2952 CFA29 
CD 
1.46 FH2377 CFA34 
1.11 FH2274 CFA02 
1.13 REN70M14 CFA02 
1.85 FH2132 CFA02 
1.91 FH2613 CFA02 
1.32 FH2145 CFA03 
0.91 FH3815 CFA18 
1.80 FH4060 CFA18 
1.23 AHT125 CFA24 
1.06 FH2324 CFA25 
1.06 FH2141 CFA25 
Heart 
1.13 FH3627 CFA25 
1.07 REN303C04 CFA04 Height 
1.45 FH2360 CFA15 
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Discussion 
A chromosome-specific genome screen was completed for Havanese kindred in 
an effort to identify regions of the genome that harbor the major gene identified by the 
complex segregation analysis in Chapter III (Starr et al. 2007). The lack of obvious 
candidate genes prohibited a candidate gene approach; therefore, linkage analysis was 
employed as an alternative in order to narrow the search for causative genes. The lack of 
statistically significant LOD scores necessitates the collection of marker data for the 
remaining chromosomes for the Havanese kindred. Insignificant LOD scores may be the 
result of uninformative markers, markers chosen which were not located close enough to 
candidate genes, or poor candidate gene choices. Intriguing regions identified by the 
screen (Table 10) will be further explored by the addition of more markers.  The 
identification of four markers as having LOD scores over 1.0 for the heart trait on 
CFA02, and three markers on CFA25 suggests that these autosomes may harbor cardiac-
related QTLs or genes.   
CD was identified as being the best indicator of the overall disease phenotype 
(Starr et al. 2007) in the Havanese. Therefore, serum chemistries and CBCs for CD dogs 
and normal dogs were evaluated for additional biomarkers of disease. The hematology 
and serum chemistry results from Terpin and Roach’s evaluation of chondrodysplastic 
Alaskan Malamutes (1981) were compared to those of the Havanese to determine 
whether a similar pathological condition exists in both dog breeds. CD Alaskan 
malamutes were diagnosed with hemolytic anemia, accompanied by low Hb, and BUN, 
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CREA, TP, and ALB and increased Phosphorous, UA, and GLU, as compared to normal 
Alaskan malamutes (Terpin and Roach 1981).
The trends for AST, MCV, BUN, ALT, and MCHC were similar among affected 
dogs of the two breeds (former two- low, latter three- high), but the analyses of 
continuous data did not yield significant p-values between normal and CD Havanese. 
Fletch et al. also described hemolytic anemia in a colony of chondrodysplastic Alaskan 
malamutes by observing high (>3:1) Hct : Hgb ratios (1973). Such ratios were not 
observed in the Havanese population, and the data described herein do not support the 
theory that CD-affected Havanese have hemolytic anemia. Serum chemistry and CBCs 
have been completed for CD-affected Scottish deerhounds (Breur et al. 1989) and 
chondrodysplastic dwarf Samoyeds (Meyers et al. 1983) for which no differences 
between CD-affected and normal dogs were observed in the CBC or serum chemistries.  
The failure to identify any biochemical parameters that are statistically different 
between normal and CD-affected dogs necessitated the classification of serum chemistry 
and CBC values using a standard reference range (Aiello 1998). Using the two-category 
classification scheme (normal/abnormal), GGT was identified as a differential biomarker 
between the two groups (p-value 0.0195, 1DF). GGT is a liver enzyme that is widely 
used as a measure of hepatic and biliary disorders in medicine. A recent study by 
Hiramatsu et al (2007) identified GGT as having cytokine activity that stimulates 
osteoclastogenesis independent of its enzymatic activity. Osteoclasts are multinucleate 
cells originating from hematopoietic cells, and are responsible for bone resorption and 
calcium homeostasis. Retarded growth, cataracts, and osteoporosis have been identified 
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in GGT-deficient mice (Lieberman et al 1996, Levasseur et al 2003). Conversely, 
increased GGT levels are also associated with osteoporosis (Hiramatsu et al 2007), 
indicating the importance of maintaining normal GGT levels for optimal skeletal 
integrity. Radiological evaluation of Havanese across various age ranges has not been 
completed; such a study would be a prudent undertaking to determine whether the GGT 
cytokine activity plays a role in the pathogenesis of the Havanese skeletal abnormalities.   
The role that TP, Hct, and MCHC (3-category scoring) and GLU and MCV (2-
category) play in the overall phenotype are not understood. None of the parameters are 
singularly diagnostic, and the lack of additional significant parameters precludes any 
insight into the pathophysiologic process in the Havanese abnormalities.  
In summary, a multi-trait, chromosome-specific linkage analysis was completed 
for 20 chromosomes in Havanese kindred to narrow the search for the major causative 
gene. Several areas of interest were identified, but no significant LOD scores were 
obtained. A whole genome screen will be subsequently completed. Clinical biochemical 
parameters were evaluated for CD and normal dogs, and GGT was identified as 
statistically different. Several biochemical differences were observed in the analyses of 
the normal, and mildly, moderately, or severely affected Havanese, but did not provide 
insight as to the underlying pathology of the collection of abnormalities.  
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CHAPTER V 
CONCLUSION 
 
 An increased understanding of canine genetics has direct applications to the 
improvement of both canine and human health. The objectives of this work were to 
characterize the genetics of two complex diseases: induced atherosclerosis in a colony of 
mixed breed dogs, and a developmental disease in the Havanese breed.  
 Atherosclerosis is a common condition in humans, leading to severe health risks 
including myocardial infarction and stroke. Much is known about atherosclerosis in the 
human and mouse, aiding the work described in Chapter II. The linkage analyses 
completed for sensitive and resistant dogs failed to yield statistically significant LOD 
scores. Regions which harbored the highest LOD scores, however, were homologous to 
atherosclerosis QTLs in the mouse. Two such QTLs in the mouse (MMU04 and 
MMU08) contain several candidate genes and these will be examined further in future 
studies of atherosclerosis in the Lab-mix colony.  
An expression profile was generated for three tissues in the Lab-mix colony. The 
expression patterns and differentially regulated genes varied among the tissues. Further 
investigation of the disease profiles may yield insight into the genome-wide response 
factors and mechanisms associated with atherosclerosis.  
Chapter III describes the developmental abnormalities in the Havanese. The 
Havanese breed experiences a problematic collection of abnormalities. Because of the 
vast phenotypic array, and the number of anomalies present in the breed, it was 
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reasonable to think that the overall phenotype may be governed by multiple genes. The 
complex segregation analyses, while indicating a polygenic mode of inheritance, did 
identify the action of a major locus segregating in an autosomal recessive mode of 
inheritance.  
Autosomal recessive diseases are particularly difficult for breeders to eradicate 
from a population because of the inability to detect carriers. Approximately two-thirds of 
canine hereditary diseases are inherited in an autosomal recessive fashion (Ostrander and 
Kruglyak 2000), owing to the propagation of recessive alleles in small, closed, inbred 
populations, and the inability to effectively select against carriers without genetic tests 
for such diseases.  
The segregation of a major locus indicated that a genome screen to identify 
chromosomal regions which may harbor causative gene(s) should be performed. Chapter 
IV describes the multiplex-specific approach to linkage analyses for the collected 
Havanese kindred. Several regions of interest were identified, but no significant LOD 
scores were obtained. Future research will include the analysis of the remaining 
multiplexes in the MSS-2 and further work in identifying biomarkers for the Havanese 
developmental disease.  
An oligonucleotide microarray creates a comprehensive disease profile and 
provides a “snapshot” of biological processes involved in the disease. Biomarkers for 
early diagnosis of diseases may be identified during the course of these studies. The use 
of microarrays is a relatively recent advance. Therefore, there is no “gold standard” for 
analysis of data. The stringent statistical parameters employed in these studies may have 
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resulted in a high number of false negatives. An additional complication is the 
incomplete annotation of the Canine_2 Affymetrix GeneChip. As the chip continues to 
be annotated and the presently unknown genes are identified, further insight may be 
gained into these two diseases.  
Interestingly, while both populations and diseases studied are dramatically 
different, analyses in each population identified cholesterol-related genes. The 
heterodimer ABCG5 and ABCG8 identified by the oligonucleotide array in the 
Havanese indicated a potential cholesterol absorption and transport deficiency. Several 
chromosomes known to harbor genes involved in cholesterol biosynthesis and regulation 
have intriguing LOD scores (Chapter IV). Because only a partial genome screen was 
completed, the remaining MSS-2 markers must be analyzed to fully interpret the results 
of the screen. The identification of reverse cholesterol transport genes in both QTLs 
indicated by linkage analyses and the microarray analyses (Chapter II) provide an 
interesting pathway upon which further research in atherosclerosis in the dog can be 
based.  
In conclusion, multiple approaches were taken to identify the underlying genetics 
of atherosclerosis in a colony of mixed-breed dogs, and developmental abnormalities in 
the Havanese breed. Estimates of heritability, linkage analyses, and disease profiling 
using oligogenic nucleotide arrays were completed to better characterize the hereditary 
diseases segregating in these populations.  
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